NYKODE THERAPEUTICS ASANYKODE THERAPEUTICS ASANYKODE THERAPEUTICS ASA

NYKODE THERAPEUTICS ASA

No trades
See on Supercharts

Price target

17.360.000.00%
The 6 analysts offering 1 year price forecasts for NYKD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to NYKD in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NYKD EPS for the last quarter is −0.24 NOK despite the estimation of −0.53 NOK. In the next quarter EPS is expected to reach −0.49 NOK. Track more of NYKODE THERAPEUTICS ASA financials and stay on top of what is up with the company.
In the next quarter NYKODE THERAPEUTICS ASA revenue is expected to reach ‪30.90 M‬ NOK. Check out NYKODE THERAPEUTICS ASA revenue and earnings and make informed decisions.
According to analysts, NYKD price target is 17.36 NOK with a max estimate of 51.58 NOK and a min estimate of 2.52 NOK. Check if this forecast comes true in a year, meanwhile watch NYKODE THERAPEUTICS ASA stock price chart and keep track of the current situation with NYKD news and stock market news.
We've gathered opinions of 6 analysts rating NYKD stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.